21 Jun, 2020 Comorbidity a major concern in people with angina pectoris, says GlobalData
Posted in PharmaComorbidity is a major concern in people with angina pectoris as, in 2019, there were nearly 20 million diagnosed prevalent cases of angina pectoris in the 7MM, according to GlobalData, a leading data and analytics company. More than 60% had one or more comorbidities, the most common of which was hypertension.
Topias Lemetyinen, Managing Epidemiologist at GlobalData, comments: “Identifying the form of angina can prove critical to identifying the underlying cause. Comparing angina pectoris in persons with diabetes, hypertension and/or previous myocardial infarction to controls predicted an increased risk of death in patients with angina pectoris. Furthermore, those with undiagnosed angina pectoris have even poorer outcomes in the long term.”
In order to best treat those with angina pectoris and limit the number of preventable deaths, persons with angina should seek medical care to appropriately diagnose the form of angina being experienced and in order to identify the underlying cause of these symptoms. The underlying diseases can often be severe and can become much more difficult to treat if allowed to progress to more advanced stages.